Students completing their studies eye the future

Around 1,450 Cornell students completed their studies this month. While the December Recognition Ceremony was canceled, some shared their university experiences.

Peter Harriott ’49, chemical engineering pioneer, dies at 94

Peter Harriott ‘49, an emeritus professor of chemical engineering who taught for 48 years at Cornell and co-authored the defining textbook on unit operations, died Sept. 23 in Ithaca. He was 94.

Students best corporate sponsor in robot contest

A bit of history was made in the annual robotics competition, Dec. 7 in the atrium of Duffield Hall, where a robot created by Cornell students defeated the corporate sponsor’s robot in a head-to-head block-gathering challenge.

Researchers ‘turn off’ driver of aortic stenosis heart disease

Researchers have discovered how to “turn off” a key driver of aortic stenosis – the narrowing of the heart’s aortic valve – identifying for the first time the biological process behind certain instances of the disease.

Climate-driven disease compromises seagrass health

In an oceanic omen for climate change’s intensifying effects, Cornell-led research shows that seagrass suffers from a wasting disease and root-system deterioration.  

AI innovators to speak at Cornell BrAIn symposium Dec. 9-10

Cornell BrAIn, initiated and led by the College of Arts & Sciences, will host a two-day symposium Dec. 9-10, bringing together innovators in Artificial Intelligence (AI) and neuroscience.

Around Cornell

Prime time: First therapeutic clinical trial of C’Dots underway

C’Dots, silica-encased nanoparticles developed in the lab of engineering professor Ulrich Wiesner, have just begun their first therapeutic human clinical trial. They’re being further developed by Elucida Oncology Inc., a company co-founded by Wiesner.

Nexus Scholars Program applications now open

The program connects undergraduates with opportunities to work side by side with Cornell faculty over the summer.

Around Cornell

In toxic microbial warfare, study finds strength in numbers

A new Cornell-led study battled strains of yeast manipulated to release different toxins at tunable and controlled rates, finding that the strain with the stronger toxin can only defeat another if its initial invading population exceeds a critical frequency or size.